Direct measurement of low-density lipoprotein in diabetic patients with end-stage renal failure
Banks, M.; Wilson, G.
British Journal of Biomedical Science 64(4): 175
2007
ISSN/ISBN: 0967-4845 PMID: 18236740 Document Number: 613829
Document emailed within 1 workday
Related Documents
Srisurin, W. 2013: Comparison of low density lipoprotein cholesterol concentrations by direct measurement and Friedewald formula in diabetic patients with and without hemoglobin e disorders Journal of the Medical Association of Thailand 96(4): 407-415Yoshino, G.; Hirano, T.; Kazumi, T. 1999: New clinical application of direct and chemical measurement of low density lipoprotein cholesterol-estimation of compositional changes in triglyceride-rich lipoprotein fraction Nihon Rinsho. Japanese Journal of Clinical Medicine 57(12): 2745-2753
Yamada, K.; Tsuji, N.; Fujita, T.; Tanaka, M.; Kuribasyashi, K.; Kobayashi, D.; Watanabe, N. 2010: Comparison of Four Direct Homogeneous Methods for the Measurement of Low-Density Lipoprotein Cholesterol Clinical Laboratory 56(7-8): 327-333
Hayashi, H.; Kurata, Y.; Imanaga, Y.; Goya, K.; Oshima, K. 1998: Vitrectomy for diabetic retinopathy in patients undergoing hemodialysis for associated end-stage renal failure Retina 18(2): 156-159
Matsuda, Y. 1993: High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation Kobe Journal of Medical Sciences 39(1): 1-14
Srisurin, W. 2014: The reliability of calculated low-density lipoprotein cholesterol from four different formulas in Thai diabetic patients Journal of the Medical Association of Thailand 97(6): 589-597
Radković, O.; Dimković, N.; Radovanović, L.; Lazić, N.; Radmilović, A. 1988: End-stage renal failure due to diabetic nephropathy Srpski Arhiv Za Celokupno Lekarstvo 116(7-8): 665-673
Sobenin, I.A.; Tertov, V.V.; Orekhov, A.N. 1994: Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients International Angiology: a Journal of the International Union of Angiology 13(1): 78-83
Sathavarodom, N.; Boonyavarakul, A. 2010: Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol Journal of the Medical Association of Thailand 93(Suppl 6): S166-S172
Oida, K.; Nakai, T.; Tamai, T.; Kutsumi, Y.; Kobayashi, T.; Hayashi, T.; Yamada, S.; Takeda, R. 1982: Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia Artery 10(4): 266-285
Kim, S.B.; Yang, W.S.; Kang, E.S.; Min, W.K.; Park, J.S. 1997: Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(3): 236-242
Matsushima, T. 2007: Methods for direct assay of low density lipoprotein cholesterol Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 153-158
Charuruks, N.; Milintagas, A. 2005: Evaluation of calculated low-density lipoprotein against a direct assay Journal of the Medical Association of Thailand 88(Suppl 4): S274-S279
Okada, K.; Kuno, T.; Yanai, M.; Maeda, H.; Takahashi, S.; Hatano, M. 1988: The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis Nihon Jinzo Gakkai Shi 30(8): 1053-1062
Masquelier, M.; Vitols, S.; Peterson, C. 1986: Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice Cancer Research 46(8): 3842-3847
Nauck, M.; März, W.; Haas, B.; Wieland, H. 1996: Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated Clinical Chemistry 42(3): 424-429
Nissenson, A.R.; Port, F.K. 1989: Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders Quarterly Journal of Medicine 73(271): 1055-1062
Nissenson, A.R.; Port, F.K. 1990: Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders Quarterly Journal of Medicine 74(273): 63-74
Jakić, M.; Lovcić, V.; Klarić, D.; Mihaljević, D.; Zibar, L.; Jakić, M.; Marić, I. 2010: Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related? Collegium Antropologicum 34(Suppl 1): 181-188
Scheffer, P.G.; Bakker, S.J.; Heine, R.J.; Teerlink, T. 1997: Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography Clinical Chemistry 43(10): 1904-1912